Treatment of Stage IV(A-B) nasopharyngeal carcinoma by induction-concurrent chemoradiotherapy and accelerated fractionation: Impact of chemotherapy schemes

International Journal of Radiation Oncology Biology Physics

Volumn 66, Issue 4, 2006, Pages 1004-1010

  Yau, T K ^a   Lee, Anne W M ^a   Wong, Dominique H M ^a   Pang, Ellie S Y ^a   Ng, W T ^a   Yeung, Rebecca M W ^a   Soong, Inda S ^a  

^a PAMELA YOUDE NETHERSOLE EASTERN HOSPITAL   (Hong Kong)

Author keywords

Concurrent chemoradiotherapy; Induction; Nasopharyngeal carcinoma

Indexed keywords

CHEMOTHERAPY; HAZARDS; ONCOLOGY; PATIENT TREATMENT; RADIOTHERAPY;

CARBOPLATIN; CISPLATIN; CONCURRENT CHEMORADIOTHERAPY; NASOPHARYNGEAL CARCINOMA;

BIOMEDICAL ENGINEERING;

CARBOPLATIN; CISPLATIN; FLUOROURACIL; GEMCITABINE;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; DISEASE COURSE; DISEASE FREE INTERVAL; FEMALE; HAZARD ASSESSMENT; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; MULTIVARIATE ANALYSIS; NASOPHARYNX CANCER; OVERALL SURVIVAL; PRIORITY JOURNAL; TREATMENT FAILURE;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; CISPLATIN; DEOXYCYTIDINE; DOSE FRACTIONATION; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOPLASM STAGING; RADIOTHERAPY, CONFORMAL; SURVIVAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 33750283687     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2006.06.016     Document Type: Article

References (24)

1. Lee A.W.M., Sze W.M., Au J.S., et al. Treatment results for nasopharyngeal carcinoma in the modern era: the Hong Kong experience. Int J Radiat Oncol Biol Phys 61 (2005) 1107-1116
2. Al-Sarraf M., LeBlanc M., Giri P.G.S., et al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized Intergroup Study 0099. J Clin Oncol 16 (1998) 1310-1317
3. Wee J., Tan E.H., Tai B.C., et al. Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union against cancer stage III and IV nasopharyngeal cancer of the endemic variety. J Clin Oncol 23 (2005) 6730-6738
4. Lee A.W.M., Lau W.H., Tung S.Y., et al. Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally-advanced nasopharyngeal carcinoma: NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study Group. J Clin Oncol 23 (2005) 6966-6975
5. Langendijk J.A., Leemans Ch R., Buter J., et al. The additional value of chemotherapy to radiotherapy in locally advanced nasopharyngeal carcinoma: A meta-analyses of the published literature. J Clin Oncol 22 (2004) 4604-4612
6. Baujat B., Audry H., Bourhis J., et al. Chemotherapy in locally advanced nasopharyngeal carcinoma: An individual patient data meta-analysis of eight randomized trials and 1753 patients. Int J Radiat Oncol Biol Phys 64 (2006) 47-56
7. Chan A.T., Ma B.B., Lo Y.M., et al. Phase II study of neoadjuvant carboplatin and paclitaxel followed by radiotherapy and concurrent cisplatin in patients with locoregionally advanced nasopharyngeal carcinoma: Therapeutic monitoring with plasma Epstein-Barr virus DNA. J Clin Oncol 22 (2004) 3053-3060
8. Johnson F.M., Garden A., Palmer J.L., et al. A Phase II study of docetaxel and carboplatin as neoadjuvant therapy for nasopharyngeal carcinoma with early T status and advanced N status. Cancer 100 (2004) 991-998
9. Lee A.W.M., Yau T.K., Wong H.M., et al. Treatment of Stage IV(A-B) Nasopharyngeal carcinoma by induction-concurrent chemoradiotherapy and accelerated fractionation. Int J Radiat Oncol Biol Phys 63 (2005) 1331-1338
10. Yau T.K., Lee A.W.M., Wong D.H.M., et al. Induction chemotherapy with cisplatin and gemcitabine followed by accelerated radiotherapy and concurrent cisplatin in patients with stage IV(A-B) nasopharyngeal carcinoma. Head Neck 28 (2006) 880-887
11. Schwartz D.L., Montgomery R.B., Yueh B., et al. Phase I and initial phase II results from a trial investigating weekly docetaxel and carboplatin given neoadjuvantly and then concurrently with concomitant boost radiotherapy for locally advanced squamous cell carcinoma of the head and neck. Cancer 103 (2005) 2534-2543
12. Belani C.P., Choy H., Bonomi P., et al. Combined chemoradiotherapy regimens of paclitaxel and carboplatin for locally advanced non-small-cell lung cancer: A randomized phase II locally advanced multi-modality protocol. J Clin Oncol 23 (2005) 5883-5891
13. Dubay R.A., Rose P.G., O'Malley D.M., et al. Evaluation of concurrent and adjuvant carboplatin with radiation therapy for locally advanced cervical cancer. Gynecol Oncol 94 (2004) 121-124
14. Fleming I.D., Cooper J.S., Henson D.E., et al. American Joint Committee on Cancer: AJCC Cancer Staging Manual. 5th ed. (1997), Lippincott-Raven, Philadelphia
15. Sobin L.H., and Wittekind C. International Union Against Cancer (UICC): TNM classification of malignant tumors. 5th ed. (1997), Wiley-Liss, New York
16. Cvitkovic E., Eschwege F., Rahal M., et al. Preliminary results of trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy vs radiotherapy alone in stage IV (≥N2, M0) undifferentiated nasopharyngeal carcinoma: A positive effect on progression free survival. Int J Radiat Oncol Biol Phys 35 (1996) 463-469
17. Chua D.T., Sham J.S., Choy D., et al. Preliminary report of the Asian-Oceanian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma. Cancer 83 (1998) 2270-2283
18. De Andres L., Brunet J., Lopez-Pousa A., et al. Randomised trial of neoadjuvant cisplatin and fluorouracil versus carboplatin and fluorouracil in patients with stage IV-M0 head and neck cancer. J Clin Oncol 13 (1995) 1493-1500
19. Welkoborsky H.J., Bleier R., and Wissen-Siegert I. Antineoplastic effectiveness and unwanted side effects of polychemotherapy of extensive oro- and hypopharyngeal cancers: Results of a prospective therapy study with 5-FU/cisplatin versus 5-FU/carboplatin. Laryngol Rhinol Otol 71 (1992) 261-266
20. Douple E.B., Richmond R.C., O'Hara J.A., et al. Carboplatin as a potentiator of radiation therapy. Cancer Treat Rev 12 (1985) 111-124
21. Parliament M., Jha N., Rapp E., et al. Concurrent weekly carboplatin and radiotherapy for nasopharyngeal carcinoma: Report of a joint phase II study. Radiother Oncol 58 (2001) 131-136
22. McDermott D.F., Galindo A., Sherman R.L., et al. Inadequacy of predicted creatinine clearance as guide to chemotherapy. Cancer Treat Rep 71 (1987) 1067-1069
23. Chang G.C., Yang T.Y., Shih C.M., et al. Serial-measured versus estimated creatinine clearance in patients with non-small cell lung cnacer receiving cisplatin-based chemotherapy. J Formos Med Assoc 102 (2003) 257-261
24. Martin L., Chatelut E., Boneu A., et al. Improvement of the Cockcroft-Gault equation for predicting glomerular filtration in cancer patients. Bull Cancer 85 (1998) 631-636